Self-management including exercise, education and activity modification compared to usual care for adolescents with Osgood-Schlatter (the SOGOOD trial): protocol of a randomized controlled superiority trial
Background Osgood-Schlatter is the most frequent growth-related injury affecting about 10% of physically active adolescents. It can cause long-term pain and limitations in sports and physical activity, with potential sequela well into adulthood. The management of Osgood-Schlatter is very heterogeneous. Recent systematic reviews have found low level evidence for surgical intervention and injection therapies, and an absence of studies on conservative management. Recently, a novel self-management approach with exercise, education, and activity modification, demonstrated favorable outcomes for adolescents with patellofemoral pain and Osgood-Schlatter in prospective cohort studies. Aim The aim of this trial is to assess the effectiveness of the novel self-management approach compared to usual care in improving self-reported knee-related function in sport (measured using the KOOS-child ‘Sport/play’ subscale) after a 5-month period. Methods This trial is a pragmatic, assessor-blinded, randomized controlled trial with a two-group parallel arm design, including participants aged 10–16 years diagnosed with Osgood-Schlatter. Participants will receive 3 months of treatment, consisting of either usual care or the self-management approach including exercise, education, and activity modification, followed by 2 months of self-management. Primary endpoint is the KOOS-child ‘Sport/play’ score at 5 months. This protocol details the planned methods and procedures. Discussion The novel approach has already shown promise in previous cohort studies. This trial will potentially provide much-needed level 1 evidence for the effectiveness of the self-management approach, representing a crucial step towards addressing the long-term pain and limitations associated with Osgood-Schlatter. Trial registration Clinicaltrials.gov: NCT05174182. Prospectively registered December 30th 2021. Date of first recruitment: January 3rd 2022. Target sample size: 130 participants..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
BMC sports science, medicine & rehabilitation - 16(2024), 1 vom: 20. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Krommes, Kasper [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Activity modification |
|---|
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1186/s13102-024-00870-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055595391 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055595391 | ||
| 003 | DE-627 | ||
| 005 | 20240421064631.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240421s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13102-024-00870-0 |2 doi | |
| 035 | |a (DE-627)SPR055595391 | ||
| 035 | |a (SPR)s13102-024-00870-0-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Krommes, Kasper |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Self-management including exercise, education and activity modification compared to usual care for adolescents with Osgood-Schlatter (the SOGOOD trial): protocol of a randomized controlled superiority trial |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Background Osgood-Schlatter is the most frequent growth-related injury affecting about 10% of physically active adolescents. It can cause long-term pain and limitations in sports and physical activity, with potential sequela well into adulthood. The management of Osgood-Schlatter is very heterogeneous. Recent systematic reviews have found low level evidence for surgical intervention and injection therapies, and an absence of studies on conservative management. Recently, a novel self-management approach with exercise, education, and activity modification, demonstrated favorable outcomes for adolescents with patellofemoral pain and Osgood-Schlatter in prospective cohort studies. Aim The aim of this trial is to assess the effectiveness of the novel self-management approach compared to usual care in improving self-reported knee-related function in sport (measured using the KOOS-child ‘Sport/play’ subscale) after a 5-month period. Methods This trial is a pragmatic, assessor-blinded, randomized controlled trial with a two-group parallel arm design, including participants aged 10–16 years diagnosed with Osgood-Schlatter. Participants will receive 3 months of treatment, consisting of either usual care or the self-management approach including exercise, education, and activity modification, followed by 2 months of self-management. Primary endpoint is the KOOS-child ‘Sport/play’ score at 5 months. This protocol details the planned methods and procedures. Discussion The novel approach has already shown promise in previous cohort studies. This trial will potentially provide much-needed level 1 evidence for the effectiveness of the self-management approach, representing a crucial step towards addressing the long-term pain and limitations associated with Osgood-Schlatter. Trial registration Clinicaltrials.gov: NCT05174182. Prospectively registered December 30th 2021. Date of first recruitment: January 3rd 2022. Target sample size: 130 participants. | ||
| 650 | 4 | |a Osgood-Schlatter |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Apophysitis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Adolescents |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Sport |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Physical activity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Knee |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Ultrasound |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Conservative treatment |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Activity modification |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Self-management |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Load management |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Thorborg, Kristian |e verfasserin |4 aut | |
| 700 | 1 | |a Clausen, Mikkel Bek |e verfasserin |4 aut | |
| 700 | 1 | |a Rathleff, Michael Skovdal |e verfasserin |4 aut | |
| 700 | 1 | |a Olesen, Jens Lykkegaard |e verfasserin |4 aut | |
| 700 | 1 | |a Kallemose, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Hölmich, Per |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC sports science, medicine & rehabilitation |d BioMed Central, 2013 |g 16(2024), 1 vom: 20. Apr. |w (DE-627)SPR030260434 |w (DE-600)2719537-5 |x 2052-1847 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2024 |g number:1 |g day:20 |g month:04 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s13102-024-00870-0 |m X:SPRINGER |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2024 |e 1 |b 20 |c 04 | ||